Gout Therapeutics Market Size, Share, And Growth Report 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Gout Therapeutics Market, 2016-2025 (USD Million)
  • 2.2. Gout Therapeutics Market: Snapshot
•  
• Chapter 3. Gout Therapeutics Market - Industry Analysis
  • 3.1. Gout Therapeutics Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. A rise in the prevalence of gout arthritis
    • 3.2.2. Increase in patient preference for biologics
    • 3.2.3. Introduction of urate-lowering agents
  • 3.3. Restraints
    • 3.3.1. Competition from generic drugs
    • 3.3.2. The high cost of biologics
  • 3.4. Opportunity
    • 3.4.1. Promising drug pipeline and approvals
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by drug type
    • 3.6.2. Market attractiveness analysis by disease condition
    • 3.6.3. Market attractiveness analysis by distribution channel
    • 3.6.4. Market attractiveness analysis by region
•  
• Chapter 4. Gout Therapeutics Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global gout therapeutics market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New product launches
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
  • 4.3. Price trend analysis
•  
• Chapter 5. Global Gout Therapeutics Market - Drug Type Analysis
  • 5.1. Global gout therapeutics market overview: by drug type
    • 5.1.1. Global gout therapeutics market share, by drug type, 2018 and 2025
  • 5.2. Colchicine
    • 5.2.1. Global gout therapeutics market by colchicine, 2016-2025 (USD Million)
  • 5.3. Antihyperuricemic Agents
    • 5.3.1. Global gout therapeutics market by Antihyperuricemic agents, 2016-2025 (USD Million)
  • 5.4. Non-Steroidal Anti-Inflammatory Drugs
    • 5.4.1. Global gout therapeutics market by non-steroidal anti-inflammatory drugs, 2016-2025 (USD Million)
  • 5.5. Corticosteroids
    • 5.5.1. Global gout therapeutics market by corticosteroids, 2016-2025 (USD Million)
  • 5.6. Biologics
    • 5.6.1. Global gout therapeutics market by biologics, 2016-2025 (USD Million)
•  
• Chapter 6. Global Gout Therapeutics Market -Disease Condition Analysis
  • 6.1. Global gout therapeutics market overview: by disease condition
    • 6.1.1. Global gout therapeutics market share, by disease condition, 2018 and 2025
  • 6.2. Acute Gout
    • 6.2.1. Global gout therapeutics market by acute gout, 2016-2025 (USD Million)
  • 6.3. Chronic Gout
    • 6.3.1. Global gout therapeutics market by chronic gout, 2016-2025 (USD Million)
•  
• Chapter 7. Global Gout Therapeutics Market - Distribution Channel Analysis
  • 7.1. Global gout therapeutics market overview: by distribution channel
    • 7.1.1. Global gout therapeutics market share, by distribution channel, 2018 and 2025
  • 7.2. Retail Pharmacy
    • 7.2.1. Global gout therapeutics market by retail pharmacy, 2016-2025 (USD Million)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global gout therapeutics market by hospital pharmacy, 2016-2025 (USD Million)
  • 7.4. Online Sales
    • 7.4.1. Global gout therapeutics market by online sales, 2016-2025 (USD Million)
•  
• Chapter 8. Global Gout Therapeutics Market - Regional Analysis
  • 8.1. Global gout therapeutics market overview: by region
    • 8.1.1. Global gout therapeutics market share, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America gout therapeutics market, 2016-2025 (USD Million)
    • 8.2.2. North America gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
    • 8.2.3. North America gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
    • 8.2.4. North America gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.2.5. The U.S.
      • 8.2.5.1. The U.S. gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.2.5.2. The U.S. gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.2.5.3. The U.S. gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.2.6.2. Rest of North America gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.2.6.3. Rest of North America gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe gout therapeutics market, 2016-2025 (USD Million)
    • 8.3.2. Europe gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
    • 8.3.3. Europe gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
    • 8.3.4. Europe gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.3.5. UK
      • 8.3.5.1. U.K. gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.3.5.2. U.K. gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.3.5.3. U.K. gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.3.6.2. France gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.3.6.3. France gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.3.7. Germany
      • 8.3.7.1. Germany gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.3.7.2. Germany gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.3.7.3. Germany gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of Europe gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.3.8.2. Rest of Europe gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.3.8.3. Rest of Europe gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific gout therapeutics market, 2016-2025 (USD Million)
    • 8.4.2. Asia Pacific gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
    • 8.4.3. Asia Pacific gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
    • 8.4.4. Asia Pacific gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.4.5. China
      • 8.4.5.1. China gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.4.5.2. China gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.4.5.3. China gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.4.6. Japan
      • 8.4.6.1. Japan gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.4.6.2. Japan gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.4.6.3. Japan gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.4.7. India
      • 8.4.7.1. India gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.4.7.2. India gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.4.7.3. India gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.4.8.2. Rest of Asia Pacific gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.4.8.3. Rest of Asia Pacific gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America gout therapeutics market, 2016-2025 (USD Million)
    • 8.5.2. Latin America gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
    • 8.5.3. Latin America gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
    • 8.5.4. Latin America gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.5.5.2. Brazil gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.5.5.3. Brazil gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
    • 8.5.6. Rest of Latin America
      • 8.5.6.1. Rest of Latin America gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
      • 8.5.6.2. Rest of Latin America gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
      • 8.5.6.3. Rest of Latin America gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa gout therapeutics market, 2016-2025 (USD Million)
    • 8.6.2. The Middle East and Africa gout therapeutics market revenue, by drug type, 2016-2025 (USD Million)
    • 8.6.3. The Middle East and Africa gout therapeutics market revenue, by disease condition, 2016-2025 (USD Million)
    • 8.6.4. The Middle East and Africa gout therapeutics market revenue, by distribution channel, 2016-2025 (USD Million)
•  
• Chapter 9. Company Profiles
  • 9.1. Teijin Pharma
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Takeda Pharmaceutical
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Novartis
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Mylan
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. Horizon Pharma
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Development
  • 9.6. Teva Pharmaceutical
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Development
  • 9.7. Iroko Pharmaceuticals
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Development
  • 9.8. Hikma Pharmaceuticals
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Development
  • 9.9. Merck
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global gout therapeutics market, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global gout therapeutics market attractiveness, by drug type
6. Global gout therapeutics market attractiveness, by disease condition
7. Global gout therapeutics market attractiveness, by distribution channel
8. Global gout therapeutics market attractiveness, by region
9. Global gout therapeutics market share, by drug type, 2018 and 2025
10. Global gout therapeutics market by colchicine, 2016–2025 (USD Million)
11. Global gout therapeutics market by Antihyperuricemic agents, 2016–2025 (USD Million)
12. Global gout therapeutics market by non-steroidal anti-inflammatory drugs, 2016–2025 (USD Million)
13. Global gout therapeutics market by corticosteroids, 2016–2025 (USD Million)
14. Global gout therapeutics market by biologics, 2016–2025 (USD Million)
15. Global gout therapeutics market share, by disease condition, 2018 and 2025
16. Global gout therapeutics market by acute gout, 2016–2025 (USD Million)
17. Global gout therapeutics market by chronic gout, 2016–2025 (USD Million)
18. Global gout therapeutics market share, by distribution channel, 2018 and 2025
19. Global gout therapeutics market by retail pharmacy, 2016–2025 (USD Million)
20. Global gout therapeutics market by hospital pharmacy, 2016–2025 (USD Million)
21. Global gout therapeutics market by online sales, 2016–2025 (USD Million)
22. Global gout therapeutics market share, by region, 2018 and 2025
23. North America gout therapeutics market, 2016–2025 (USD Million)
24. Europe gout therapeutics market, 2016–2025 (USD Million)
25. Asia Pacific gout therapeutics market, 2016–2025 (USD Million)
26. Latin America gout therapeutics market, 2016–2025 (USD Million)
27. The Middle East and Africa gout therapeutics market, 2016–2025 (USD Million)

Table Of Tables

List of Tables

1. Global gout therapeutics market: Snapshot
2. Drivers of the gout therapeutics market: impact analysis
3. Restraints of the gout therapeutics market: impact analysis
4. North America gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
5. North America gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
6. North America gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
7. The U.S. gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
8. The U.S. gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
9. The U.S. gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
10. Rest of North America gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
11. Rest of North America gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
12. Rest of North America gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
13. Europe gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
14. Europe gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
15. Europe gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
16. U.K. gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
17. U.K. gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
18. U.K. gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
19. France gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
20. France gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
21. France gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
22. Germany gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
23. Germany gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
24. Germany gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
25. Rest of Europe gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
26. Rest of Europe gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
27. Rest of Europe gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
28. Asia Pacific gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
29. Asia Pacific gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
30. Asia Pacific gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
31. China gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
32. China gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
33. China gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
34. Japan gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
35. Japan gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
36. Japan gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
37. India gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
38. India gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
39. India gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
40. Rest of Asia Pacific gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
41. Rest of Asia Pacific gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
42. Rest of Asia Pacific gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
43. Latin America gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
44. Latin America gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
45. Latin America gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
46. Brazil gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
47. Brazil gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
48. Brazil gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
49. Rest of Latin America gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
50. Rest of Latin America gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
51. Rest of Latin America gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)
52. The Middle East and Africa gout therapeutics market revenue, by drug type, 2016–2025 (USD Million)
53. The Middle East and Africa gout therapeutics market revenue, by disease condition, 2016–2025 (USD Million)
54. The Middle East and Africa gout therapeutics market revenue, by distribution channel, 2016–2025 (USD Million)